Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges

Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges

Orgilmaa Regzedmaa,1 Hongbing Zhang,1 Hongyu Liu,2 Jun Chen1,21Department of Lung Cancer Surgery, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, People’s Republic of China; 2Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenviron...

Full description

Bibliographic Details
Main Authors: Regzedmaa O, Zhang H, Liu H, Chen J
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:OncoTargets and Therapy
Subjects:
Small cell lung cancer
Immune checkpoint inhibitors
Cytotoxic T lymphocyte-associated protein-4 (CTLA-4)
Programmed cell death protein-1 (PD-1)
Programmed cell death ligand-1 (PD-L1)
Next generation of immune checkpoints
Online Access:https://www.dovepress.com/immune-checkpoint-inhibitors-for-small-cell-lung-cancer-opportunities--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/immune-checkpoint-inhibitors-for-small-cell-lung-cancer-opportunities--peer-reviewed-article-OTT

Similar Items